Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 20 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 9868954

    Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  2. US 9867785

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  3. US 9862928

    Generation of natural killer cells and lymphoid tissue inducer-like (LTi-like) NK-22 cells

    Regents of the University of Minnesota · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  4. US 9855347

    Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

    Aura Biosciences, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  5. US 9849167

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  6. US 9846160

    Ganglioside GD2 as a marker and target on cancer stem cells

    The Board of Regents of the University of Texas System · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  7. US 9844598

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  8. US 9844569

    Methods of producing enriched populations of tumor reactive T cells from peripheral blood

    The United State of America, as Represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  9. US 9833479

    Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

    Sangamo Therapeutics, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  10. US 9834787

    Targeted integration into stem cells

    Sangamo Therapeutics, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  11. US 9828634

    Markers for differentiation of stem cells into differentiated cell populations

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  12. US 9816074

    Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells

    Sangamo Therapeutics, Inc. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  13. US 9814422

    Compositions for solubilizing cells and/or tissue

    The Regents of the University of California · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  14. US 9808532

    Peptides whose uptake in cells is controllable

    The Regents of the University of California · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  15. US 9808488

    Isolated populations of renal stem cells and methods of isolating and using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  16. US 9801863

    Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis

    The Board of Regents of the University of Texas System · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  17. US 9801911

    Expansion of alloantigen-reactive regulatory T cells

    The Regents of the University of California · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  18. US 9796961

    Conditionally immortalized long-term stem cells and methods of making and using such cells

    The Regents of the University of Colorado · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  19. US 9790261

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  20. US 9789136

    Multipotent adult stem cells and methods for isolation

    Regents of the University of Minnesota · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  21. US 9782337

    Methods and compositions using compounds from fetal cells and tissues to improve condition of skin

    The Regents of the University of California · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  22. US 9770469

    Methods of reprogramming renal cells

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  23. US 9763984

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  24. US 9763982

    Depletion of cancer stem cells

    The Regents of the University of California · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.